Mainstream

Generic Drugmakers Could See Negative Impact From Higher Chinese Tariffs

Generic drugmakers could see negative impact from higher Chinese tariffs

Generic drugmakers could see negative impact from higher Chinese tariffs

Post Contentvtrs, teva, mrk, lly, pfe, sdzny, sdzxfRead More

You might also be interested in reading Orix GAAP EPS of ¥94.44, revenue of ¥768.6M.

March 4, 2025
In Mainstream